Advice AbbVie says FDA approves Skyrizi for ulcerative colitis On Jun 18, 2024 0 Share AbbVie said that the heavily-advertised drug was now approved for four conditions across different so-called “immune-mediated” inflammatory diseases. Source Las Vegas News Magazine Continue Reading bankruptcy filinghousing marketMarket Predictionsretirement planningsavings planning 0 Share FacebookTwitterGoogle+ReddItWhatsAppPinterestEmailTelegram